Transformative Gene-Editing Technology - Ciente

BioCentriq® and Kytopen® Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

By PRNEWSWIREJune 6, 20230

NEWARK, N.J., June 6, 2023 /PRNewswire/ — BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy…